MI-CURE Admin
MI-CURE 管理员
基本信息
- 批准号:10491227
- 负责人:
- 金额:$ 31.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-22 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdministratorAdultAnimal ExperimentationAreaBasic ScienceBenignBladderBladder DysfunctionCellular biologyClinicalClinical ResearchCollaborationsCommunicationCommunication ToolsCommunity Health EducationConflict (Psychology)DisciplineDiseaseEducationElectronic MailEngineeringEnsureEnvironmentEquipmentFibrosisFosteringFoundationsFundingFutureGenitourinary systemGoalsGrantGuidelinesHigh School StudentHospitalsHuman ResourcesInfrastructureInterdisciplinary StudyIntuitionJointsKnowledgeLanguageLeadLeadershipLearningMechanicsMedical StudentsMentorsMentorshipMichiganMovementNational Institute of Diabetes and Digestive and Kidney DiseasesPhysiciansPhysiologyPlayPreparationProgram DevelopmentPublicationsResearchResearch PersonnelResearch Project GrantsResearch SupportResourcesRoleScheduleScienceScientistSolidStructureStudentsSumTalentsTechnologyTestingTimeTrainingUnited States National Institutes of HealthUniversitiesUrogenital DiseasesUrologistUrologyWorkafferent nervecareer developmentdata managementdata sharingdesigneducation resourcesexperienceinnovationinterdisciplinary collaborationmathematical modelmedical schoolsmeetingsmembernovelnovel therapeuticsonline resourceorganizational structureoutreachpressureprogramsrecruitsoft tissuestatisticssuccesssymposiumtraining opportunityurinaryurologicweb site
项目摘要
ABSTRACT
The Michigan Interdisciplinary Center for Urology Research and Education (MI-CURE) seeks
to develop a world-class interdisciplinary research team comprised of scientists, clinicians, biostatisticians,
and engineers to provide comprehensive and innovative approaches in benign urology. As such, we have
brought together exceptional investigators with diverse expertise from Beaumont Hospital/ Oakland
University William Beaumont School of Medicine and Michigan State University.
The overall purpose of the MI-CURE Exploratory Center is to establish strong research foundations
in bladder physiology, develop an intellectual infrastructure, and expand educational and training
opportunities in benign urology research. Despite decades of research, the mechanisms by which bladder
fullness is sensed are still unknown. A major barrier to developing and testing novel therapies for bladder
dysfunction is our lack of understanding the mechanism of how bladder fullness is sensed. Thus, the overall
goal of this initial project is to understand the basis of pressure sensing and its linkage to afferent nerve
activation during bladder filling, and consequently how bladder remodeling and altered bladder wall
compliance during disease can impact these mechanisms. To address this significant knowledge gap, we
have assembled an interdisciplinary team of experts in physiology, cell biology, fibrosis, neurourology,
statistics, and clinical urology and have recruited a promising new investigator in engineering to benign
genitourinary disease, Dr. Sara Roccabianca. She has unique expertise in soft tissue mechanical
characterization, microstructural quantification, and mathematical modeling of soft tissues movement.
In addition to the strong benign urology research program using innovative and cutting-edge
approaches, MI-CURE has an exciting Educational Enrichment Program to train and mentor all levels of
adult learners, from high school students to medical students, to help expand and enhance benign urology
research. MI-CURE is co-directed by the established physician-scientist team of Drs. Laura Lamb and
Michael Chancellor, with clear communication and coordination plans in place. Together, MI-CURE will
foster successful collaborations, education initiatives, and innovative research.
Funding of MI-CURE as a P20 Exploratory Center will allow us to work with the George M. O'Brien
Urology Cooperative Research Centers Program and the KURe and UroEpi career development programs
through joint meetings and conference calls. Our goal is to leverage our collective resources and results
into well-designed, novel projects suitable for submission as future NIH Investigator-Initiated R01s. We
strongly believe that the Michigan Interdisciplinary Center for Urology Research and Education program
as a whole will be greater than the sum of its parts and will contribute to developing talented researchers
in benign genitourinary disorders.
抽象的
密歇根泌尿学研究和教育跨学科中心 (MI-CURE) 寻求
建立一支由科学家、临床医生、生物统计学家组成的世界一流的跨学科研究团队,
和工程师提供良性泌尿外科全面和创新的方法。因此,我们有
汇集了来自奥克兰博蒙特医院的具有不同专业知识的杰出研究人员
大学威廉博蒙特医学院和密歇根州立大学。
MI-CURE 探索中心的总体目标是建立强大的研究基础
在膀胱生理学方面,开发智力基础设施,并扩大教育和培训
良性泌尿外科研究的机会。尽管经过了数十年的研究,膀胱的机制
是否感觉到饱满度仍然未知。开发和测试膀胱新疗法的主要障碍
功能障碍是我们缺乏对膀胱充盈感的机制的了解。因此,总体
这个初始项目的目标是了解压力传感的基础及其与传入神经的联系
膀胱充盈过程中的激活,以及膀胱如何重塑和改变膀胱壁
疾病期间的依从性会影响这些机制。为了解决这一重大知识差距,我们
组建了一支由生理学、细胞生物学、纤维化、神经泌尿学专家组成的跨学科团队,
统计学和临床泌尿学,并招募了一位有前途的良性工程新研究人员
泌尿生殖系统疾病,Sara Roccabianca 博士。她在软组织机械方面拥有独特的专业知识
软组织运动的表征、微观结构量化和数学建模。
除了使用创新和尖端技术的强大良性泌尿学研究计划
方法,MI-CURE 有一个令人兴奋的教育强化计划来培训和指导各个级别的
成人学习者,从高中生到医学生,帮助扩大和加强良性泌尿外科
研究。 MI-CURE 由已建立的医师科学家团队共同领导。劳拉·兰姆和
迈克尔·财政大臣,制定了明确的沟通和协调计划。 MI-CURE 将共同努力
促进成功的合作、教育举措和创新研究。
MI-CURE 作为 P20 探索中心的资助将使我们能够与 George M. O'Brien 合作
泌尿科合作研究中心计划以及 KURe 和 UroEpi 职业发展计划
通过联席会议和电话会议。我们的目标是利用我们的集体资源和成果
适合作为未来 NIH 研究者发起的 R01 提交的精心设计的新颖项目。我们
坚信密歇根泌尿外科研究和教育跨学科中心计划
整体大于各部分之和,并将有助于培养有才华的研究人员
良性泌尿生殖系统疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL B CHANCELLOR其他文献
MICHAEL B CHANCELLOR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL B CHANCELLOR', 18)}}的其他基金
Michigan Interdisciplinary Center for Urology Research and Education (MI-CURE)
密歇根泌尿外科研究和教育跨学科中心 (MI-CURE)
- 批准号:
10491200 - 财政年份:2021
- 资助金额:
$ 31.65万 - 项目类别:
Michigan Interdisciplinary Center for Urology Research and Education (MI-CURE)
密歇根泌尿外科研究和教育跨学科中心 (MI-CURE)
- 批准号:
10375149 - 财政年份:2021
- 资助金额:
$ 31.65万 - 项目类别:
Pharmacology of Intravesical Antisense Based Therapy for Over Active Bladder
膀胱内反义疗法治疗膀胱过度活动症的药理学
- 批准号:
8706852 - 财政年份:2011
- 资助金额:
$ 31.65万 - 项目类别:
Pharmacology of Intravesical Antisense Based Therapy for Over Active Bladder
膀胱内反义疗法治疗膀胱过度活动症的药理学
- 批准号:
8528570 - 财政年份:2011
- 资助金额:
$ 31.65万 - 项目类别:
Pharmacology of Intravesical Antisense Based Therapy for Over Active Bladder
膀胱内反义疗法治疗膀胱过度活动症的药理学
- 批准号:
8103682 - 财政年份:2011
- 资助金额:
$ 31.65万 - 项目类别:
Pharmacology of Intravesical Antisense Based Therapy for Over Active Bladder
膀胱内反义疗法治疗膀胱过度活动症的药理学
- 批准号:
8322516 - 财政年份:2011
- 资助金额:
$ 31.65万 - 项目类别:
Pharmacology of Intravesical Antisense Based Therapy for Over Active Bladder
膀胱内反义疗法治疗膀胱过度活动症的药理学
- 批准号:
8432297 - 财政年份:2011
- 资助金额:
$ 31.65万 - 项目类别:
Intravesical liposome drug delivery to treat interstitial cystitis
膀胱内脂质体给药治疗间质性膀胱炎
- 批准号:
8088108 - 财政年份:2010
- 资助金额:
$ 31.65万 - 项目类别:
Intravesical liposome drug delivery to treat interstitial cystitis
膀胱内脂质体给药治疗间质性膀胱炎
- 批准号:
7779795 - 财政年份:2010
- 资助金额:
$ 31.65万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Predicting firearm suicide in military veterans outside the VA health system using linked civilian electronic health record data
使用链接的民用电子健康记录数据预测退伍军人管理局卫生系统外退伍军人的枪支自杀
- 批准号:
10655968 - 财政年份:2023
- 资助金额:
$ 31.65万 - 项目类别:
Characteristics and outcomes for hospitalized patients with methamphetamine and opioid co-use: Identifying opportunities for hospital-based addiction services tailored to co-use
甲基苯丙胺和阿片类药物同时使用的住院患者的特征和结果:确定针对共同使用的医院成瘾服务的机会
- 批准号:
10677138 - 财政年份:2023
- 资助金额:
$ 31.65万 - 项目类别:
Characteristics and outcomes for hospitalized patients with methamphetamine and opioid co-use: Identifying opportunities for hospital-based addiction services tailored to co-use
甲基苯丙胺和阿片类药物同时使用的住院患者的特征和结果:确定针对共同使用的医院成瘾服务的机会
- 批准号:
10677138 - 财政年份:2023
- 资助金额:
$ 31.65万 - 项目类别:
Feasibility Trial of a Novel Integrated Mindfulness and Acupuncture Program to Improve Outcomes after Spine Surgery (I-MASS)
旨在改善脊柱手术后效果的新型综合正念和针灸计划的可行性试验(I-MASS)
- 批准号:
10649741 - 财政年份:2023
- 资助金额:
$ 31.65万 - 项目类别:
Impact of the MISSION Act on Quality and Outcomes of Interventional Cardiology and Cardiac Surgery among Veterans
《使命法案》对退伍军人介入心脏病学和心脏手术的质量和结果的影响
- 批准号:
10640085 - 财政年份:2022
- 资助金额:
$ 31.65万 - 项目类别: